Abstract
Background
Data on stroke risk factor profiles and atrial fibrillation (AF) for the Chinese population are sparse. This study identified risk factors for stroke among native Chinese with nonrheumatic AF.
Methods
In this retrospective investigation, patients diagnosed with nonrheumatic AF were identified from 18 hospitals in representative areas of the country, from January 2000 to April 2002, based on the medical records. All parameters relevant to AF were compared between AF patients with stroke and those without. The independent risk factors for stroke were assessed with a logistic regression analysis.
Results
Patients numbering 3,425 with AF were included, among whom 827 subjects were discharged on account of stroke. The prevalence of stroke in nonrheumatic AF patients was 24.15%. AF patients with stroke were significantly older than controls (73.31 ± 9.18 versus 68.22 ± 12.29 y, p < 0.001) and more likely to have a history of hypertension (71.0 versus 51.6%, p < 0.001) and diabetes (17.9 versus 11.1%, p = 0.001).
Both, systolic and diastolic blood pressure, are significantly higher in patients with stroke. Of all the parameters of echocardiography, there was strong evidence that left atrial (LA) thrombi significantly increased risk of stroke. Patients with persistent AF were more likely to have stroke than paroxysmal AF patients, while lone AF is less in patients with stroke than in those without. The rate of anticoagulation treatment is only 9.27%, but there were no significant differences between the 2 groups. In multivariate analysis, age ≥ 75 y (odds ratio [OR] 1.76; 95% confidence interval [CI] 1.08‐2.98), history of hypertension (OR 1.52; 95% CI 1.28‐1.80), diabetes (OR 1.39; 95% CI 1.11‐1.76), high systolic blood pressure (OR 1.71; 95% CI 1.21‐2.28), LA thrombi (OR 2.77; 95% CI 1.25‐6.13) were independent predictors for stroke.
Conclusions
The prevalence of stroke in hospitalized nonrheumatic AF patients was high. The population‐specific risk factors for stroke were age ≥ 75 y, diabetes, history of hypertension, high systolic blood pressure and LA thrombi by transesophageal echocardiography (TEE). These merit further evaluation. Copyright © 2009 Wiley Periodicals, Inc.
Keywords: atrial fibrillation, stroke, risk factor, warfarin
Full Text
The Full Text of this article is available as a PDF (117.9 KB).
References
- 1. Wolf PA, Abbott RD, Kannel WB: Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke 1991; 22: 983–988. [DOI] [PubMed] [Google Scholar]
- 2. Hart RG, Benavente O, McBride R, Pearce LA: Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: A meta‐analysis. Ann Intern Med 1999; 1(31): 492–501. [DOI] [PubMed] [Google Scholar]
- 3. Wen‐Hang QI, Society of Cardiology, Chinese Medical Association: Retrospective investigation of hospitalised patients with atrial fibrillation in mainland China. Int J Cardiol 2005; 105(3): 283–287. [DOI] [PubMed] [Google Scholar]
- 4. He J, Gu D, Wu X, Reynolds K, Duan X, et al.: Major causes of death among men and women in China. N Engl J Med 2005; 353(11): 1124–1134. [DOI] [PubMed] [Google Scholar]
- 5. Report of the WHO task force on stroke and other cerebrovascular disorders: Stroke‐1989: recommendations on stroke prevention, diagnosis, and therapy. Stroke 1989; 20: 1407–1431. [DOI] [PubMed] [Google Scholar]
- 6. Hart RG, Pearce LA, McBride R, Rothbart RM, Asinger RW, Stroke Prevention in Atrial Fibrillation (SPAF) Investigators: Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I‐III clinical trials. Stroke 1999; 30: 1223–1229. [DOI] [PubMed] [Google Scholar]
- 7. Brignole M, Gianfranchi L, Menozzi C, Alboni P, Musso G, et al: Assessment of atrioventricular junction ablation and DDDR mode‐switching pacemaker versus pharmacological treatment in patients with severely symptomatic paroxysmal atrial fibrillation: a randomized controlled study. Circulation 1997; 96: 2617–2624. [DOI] [PubMed] [Google Scholar]
- 8. Fihn SD, Callahan CM, Martin DC, McDonell MB, Henikoff JG, et al., National Consortium of Anticoagulation Clinics: The risk for and severity of bleeding complications in elderly patients treated with warfarin. Ann Intern Med 1996; 124: 970–979. [DOI] [PubMed] [Google Scholar]
- 9. Stroke prevention in atrial fibrillation committee on echocardiography: Transesophageal echocardiographic correlates of thromboembolism in high‐risk patients with atrial fibrillation. Ann Intern Med 1998; 128: 639–647. [DOI] [PubMed] [Google Scholar]
- 10. The AFFIRM Investigators: A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002; 34: 1825–1833. [DOI] [PubMed] [Google Scholar]
- 11. Aschenberg W, Schluter M, Kremer P, Schroder E, Siglow V, et al.: Transesophageal two‐dimensional echocardiography for the detection of left atrial appendage thrombus. J Am Coll Cardiol 1986; 7: 163–166. [DOI] [PubMed] [Google Scholar]
- 12. The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators: Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study. JAMA 1998; 279: 1273–1277. [PubMed] [Google Scholar]
- 13. AF Investigators: Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994; 154: 1449–1457. [PubMed] [Google Scholar]
- 14. Go AS, Hylek EM, Phillips KA, Borowsky LH, Henault LE, et al.: Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. Circulation 2000; 102(1): 11–13. [DOI] [PubMed] [Google Scholar]
- 15. Nieuwlaat R, Capucci A, Camm AJ, Olsson SB, Andresen D, et al., European Heart Survey Investigators: Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation. Eur Heart J 2005; 26(22): 2422–2434. [DOI] [PubMed] [Google Scholar]
- 16. Leung CS, Tam KM: Antithrombotic treatment of atrial fibrillation in a regional hospital in Hong Kong. Hong Kong Med J 2003; 9(3): 179–185. [PubMed] [Google Scholar]